Focus Areas

Innovative Neuro Research


Recurrent, spontaneous seizures

  • Blocking the development of epilepsy & stopping seizures
  • Post traumatic epilepsy
  • Innovative techniques to reproduce human epilepsies in the lab


Loss of neurons in the brain

  • New model development
  • Traumatic Brain Injury
  • Alzheimer's Disease


Innovative techniques to illuminate neurological challenges

  • Neurodegenerative diseases
  • Epilepsy
  • Traumatic brain injury

Other Research

Active interest in:

  • Biomarker development
  • Non-invasive Neurostimulation
  • Human microbiome (“the Second Brain”)
Current Projects at Expesicor
People with Epilepsy
Traumatic Brain Injury (TBI) cases each year
People with Alzheimer's and Parkinson's
Meet the Team

Expesicor Leadership

Braxton Norwood PhD
Neuroscientist with substantial experience in epilepsy R&D. NIH Young Investigator Award. CURE Foundation Challenge Award.
David Booth
Bioentrepreneur and investor
David Henshall PhD
Scientific Advisory Board
Felix Rosenow MD
Scientific Advisory Board
Matthew Walker MD
Scientific Advisory Board
Matthias Schönberger PhD
Scientific Advisory Board
Tally Largent-Milnes PhD
Scientific Advisory Board
Cindi Laukes MA, MFA
Scientific Advisory Board
Expect a response within 48 hours
Contact Us

“Epilepsy R&D is long overdue for a breakthrough, and the KaL method may be just that.”

Tom Swanson, MD, Director of the MT Comprehensive Epilepsy Center